cns.jpg (2811 bytes)

Subscription

Reprints

Journal Home
Contents
Editorial Board
Instructions for Contributors
Subscription Rates


© Neva Press, Inc. 2005


CNS Drug Reviews

Table of Contents

Volume 3, No. 3

Reviews
207 A Review of the Preclinical Development of Zaleplon, a Novel Non-Benzodiazepine Hypnotic for the Treatment of Insomnia
B. Beer, D. E. Clody, R. Mangano, M. Levner, P. Mayer and J. E. Barrett
225 Losigamone:   From Plant Extract to Antiepileptic Drug
S. S. Chatterjee and M. Nöldner
245 Cognition Enhancing Profile of CR 2249, a new NMDA-Glycine Site Modulator
Marco Lanza and Francesco Makovec
260 Propentofylline (HWA 285), a Neuroprotective Glial Cell Modulator:  Pharmacologic Profile
K. Rudolphi, C. K. Park and M. Rother
278 Biochemical and Behavioral Pharmacology of RS-102221, a Subtype Selective 5-HT2C Receptor Antagonist
Douglas W. Bonhaus, Klaus W. Weinhardt, Mike Taylor, Andrea De Souza, Patty M. McNeeley, Krystein Szcepanski, David J. Fontana, Julianne Trinh, Cynthia L. Rocha, Mark W. Dawson, Zhen Cao, Lynette Wong and Richard M. Eglen
Meeting Reports
294 Advances in Serotonin Receptor Research:  Molecular Biology, Signal Transduction and Therapeutics.  San Francisco, CA.  October 8-10, 1997
Graeme R. Martin